Principally, MDM2 and CDK4 examination allows differentiation of WDLPS from benign adipose tumors while in DDLPS, MDM2 and CDK4 evaluation help to exclude poorly differentiated sarcomas [26]. The gene discussed is CDK4; the disease is sarcoma.